Evolution of the Average Target: Sartorius AG

Evolution of the Target Price: Sartorius AG

Changes in Analyst Recommendations: Sartorius AG

79.IaJMTmwAuRELx0YLTbQSGl8Rxm8hTWyHYHaKVwCY_9k.bZAGdjtJ1ltj8wt9GPh4TT19rjhgGlnBVBPmenTMy-5iyjQrGUveZG6GKQ~17bf240f01167ff6f7bf59ad1e51957b
06-08 Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk MT
06-05 Sartorius AG out of favor, as mwb research maintains Sell rating Zonebourse
05-26 Sartorius AG Price Target, Estimates Down at AlphaValue/Baader Europe Post-FY26 Guidance MT
05-25 Sartorius: Trimming the new baseline Alphavalue
05-25 AlphaValue/Baader Europe Cuts Forecasts, Price Target for Sartorius Stedim Biotech on FY26 Outlook MT
05-06 SARTORIUS VORZUEGE : RBC remains Neutral ZD
04-27 SARTORIUS VORZUEGE : Goldman Sachs sticks Neutral ZD
04-27 SARTORIUS VORZUEGE : Raised to Buy by Berenberg ZD
04-27 Berenberg upgrades Sartorius to 'Buy' - Price target raised to 250 euros DP
04-24 SARTORIUS VORZUEGE : UBS gives a Neutral rating ZD
04-24 SARTORIUS VORZUEGE : DZ Bank gives a Neutral rating ZD
04-24 Sartorius: Resilient Q1; H2 recovery is the key watchpoint Alphavalue
04-23 SARTORIUS VORZUEGE : Barclays gives a Buy rating ZD
04-23 SARTORIUS VORZUEGE : Jefferies reiterates its Buy rating ZD
04-23 SARTORIUS VORZUEGE : RBC reiterates its Neutral rating ZD
04-23 SARTORIUS VORZUEGE : Bernstein remains its Buy rating ZD
04-23 SARTORIUS VORZUEGE : JP Morgan gives a Buy rating ZD
04-23 SARTORIUS VORZUEGE : UBS reaffirms its Neutral rating ZD
04-23 SARTORIUS VORZUEGE : Goldman Sachs remains Neutral ZD
04-23 Goldman maintains 'Neutral' rating on Sartorius - Target 232 euros DP
04-17 SARTORIUS VORZUEGE : UBS reaffirms its Neutral rating ZD
04-10 SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating ZD
04-10 JPMorgan Maintains Overweight Rating on Sartorius with 295 Euro Price Target DP
03-30 Goldman Sachs upgrades Sartorius Stedim Biotech to Buy Zonebourse
03-30 SARTORIUS VORZUEGE : Goldman Sachs gives a Neutral rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +64.13%
+44.16%
+31.81%
+99.35%
+63.04%
+43.31%
+29.52%
Average +53.62%
Weighted average by Cap. +54.34%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
231.20EUR
Average target price
266.37EUR
Spread / Average Target
+15.21%
High Price Target
307.00EUR
Spread / Highest target
+32.79%
Low Price Target
190.00EUR
Spread / Lowest Target
-17.82%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Jitisha Malhotra
RBC Charles Weston
DZ BANK Sven Kürten
BERENBERG Harry Gillis
GOLDMAN SACHS James Quigley
UBS Matthew Weston
JPMORGAN Richard Vosser
BERNSTEIN RESEARCH Delphine Le Louet
JEFFERIES James Vane-Tempest
BARCLAYS Charles Pitman-King
DEUTSCHE BANK RESEARCH Falko Friedrichs
Morningstar
WARBURG RESEARCH Michael Heider
AlphaValue/Baader Europe
ODDO BHF Oliver Metzger
CREDIT SUISSE Dominic Lunn
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
231.20EUR
Average target price
266.37EUR
Spread / Average Target
+15.21%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!